PLYGFPolyPeptide Group AG
Mkt Cap
$783.41MVolume
550.0052W High
$34.2552W Low
$34.25PE Ratio
-29.86PLYGF Fundamentals
Price
$34.25Open
$34.2550D MA
$27.40Beta
0.00Avg. Volume
0.00EPS (Annual)
-$0.6417P/B
2.91Rev/Employee
$267,477.82PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. It operates through the following business areas: Custom Projects, Contract Manufacturing, and Generics and Cosmetics. The Custom Projects business area includes manufacturing of custom research-grade peptides and oligonucleotides for use in pre-clinical and clinical development as well as for regulatory and scientific studies. The Contract Manufacturing business area focuses on peptides for commercial stage peptide therapeutics, at scale, in commercial batches and in accordance with current Good Manufacturing Practice (cGMP) requirements. The Generics and Cosmetics business area is involved in peptide-based generics for the human and veterinary market, produced on an industrial scale following cGMP guidelines. The company was founded in 1952 and is headquartered in Baar, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,362
Frequently Asked Questions
What is Market Cap of PolyPeptide Group AG?
What is the 52-week high for PolyPeptide Group AG?
What is the 52-week low for PolyPeptide Group AG?
What is PolyPeptide Group AG stock price today?
What is the PE ratio of PolyPeptide Group AG?
What is the Price-to-Book ratio of PolyPeptide Group AG?
What is the 50-day moving average of PolyPeptide Group AG?
How many employess does PolyPeptide Group AG has?